E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/22/2009 in the Prospect News Municipals Daily.

Fred Hutchinson Cancer Research, Wash., to sell $115.39 million bonds

By Sheri Kasprzak

New York, Oct. 22 - The Washington Health Care Facilities Authority is expected to price $115.39 million in series 2009A revenue bonds for the Fred Hutchinson Cancer Research Center, according to a preliminary official statement.

The bonds (A2/A/) will be sold on a negotiated basis with Barclays Capital Inc. as the senior manager. The co-managers are J.P. Morgan Securities Inc. and Merrill Lynch & Co.

The bonds are due 2010 to 2033 with a term bond.

Proceeds will be used to refund the cancer center's series 2001B and 2002 bonds.

The Fred Hutchinson Cancer Research Center is located in Seattle.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.